Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.

about

DNA-encoded chemical libraries: Achievements and remaining challenges.

P2860

Q52570390-00F8FCA4-B2EA-46DA-9A10-1590AC253D2C

P2860

Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.

Item

http://www.wikidata.org/entity/Q48307732

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Target Identification of Kinas ...... -Programmed Affinity Labeling.

@en

Target Identification of Kinase Inhibitor Alisertib

@nl

type

Item

label

Target Identification of Kinas ...... -Programmed Affinity Labeling.

@en

Target Identification of Kinase Inhibitor Alisertib

@nl

prefLabel

Target Identification of Kinas ...... -Programmed Affinity Labeling.

@en

Target Identification of Kinase Inhibitor Alisertib

@nl

P1476

Target Identification of Kinas ...... A-Programmed Affinity Labeling

@en

P2093

Dong-Yao Wang

http://www.w3.org/2001/XMLSchema#string

Lang-Dong Chen

http://www.w3.org/2001/XMLSchema#string

Le-Yi Zheng

http://www.w3.org/2001/XMLSchema#string

Xiao-Fei Chen

http://www.w3.org/2001/XMLSchema#string

Yan Cao

http://www.w3.org/2001/XMLSchema#string

Yi-Feng Chai

http://www.w3.org/2001/XMLSchema#string

Zhan-Ying Hong

http://www.w3.org/2001/XMLSchema#string

Zhen-Yu Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases

Aurora Kinase Inhibitors: Current Status and Outlook

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?

Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis

Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b

Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237

Chemical proteomics approaches for identifying the cellular targets of natural products

Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions

Comprehensive analysis of kinase inhibitor selectivity

P304

10906-10914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201702033

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiaoyu Li

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28594098

http://www.w3.org/2001/XMLSchema#string

Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.

about

P2860

P2860

Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698